Working… Menu

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03387085
Recruitment Status : Unknown
Verified May 2019 by ImmunityBio, Inc..
Recruitment status was:  Active, not recruiting
First Posted : December 29, 2017
Last Update Posted : May 17, 2019
Information provided by (Responsible Party):
ImmunityBio, Inc.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : January 2020